In last trading session, Sana Biotechnology Inc (NASDAQ:SANA) saw 1.73 million shares changing hands with its beta currently measuring 1.44. Company’s recent per share price level of $4.27 trading at $0.51 or 13.56% at ring of the bell on the day assigns it a market valuation of $949.95M. That closing price of SANA’s stock is at a discount of -181.03% from its 52-week high price of $12.00 and is indicating a premium of 35.83% from its 52-week low price of $2.74. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.87 million shares which gives us an average trading volume of 1.70 million if we extend that period to 3-months.

For Sana Biotechnology Inc (SANA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.67. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.27 in the current quarter.

Sana Biotechnology Inc (NASDAQ:SANA) trade information

Upright in the green during last session for gaining 13.56%, in the last five days SANA remained trading in the red while hitting it’s week-highest on Friday, 09/20/24 when the stock touched $4.27 price level, adding 7.78% to its value on the day. Sana Biotechnology Inc’s shares saw a change of 4.66% in year-to-date performance and have moved -7.58% in past 5-day. Sana Biotechnology Inc (NASDAQ:SANA) showed a performance of -26.12% in past 30-days. Number of shares sold short was 31.17 million shares which calculate 22.79 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 12 to the stock, which implies a rise of 64.42% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 12. It follows that stock’s current price would drop -181.03% in reaching the projected high whereas dropping to the targeted low would mean a loss of -181.03% for stock’s current value.

Sana Biotechnology Inc (SANA) estimates and forecasts

Statistics highlight that Sana Biotechnology Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -57.30% of value to its shares in past 6 months, showing an annual growth rate of 27.61% while that of industry is 17.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -83.13% during past 5 years.

Sana Biotechnology Inc (NASDAQ:SANA)’s Major holders

Insiders are in possession of 8.60% of company’s total shares while institution are holding 90.39 percent of that, with stock having share float percentage of 98.89%. Investors also watch the number of corporate investors in a company very closely, which is 90.39% institutions for Sana Biotechnology Inc that are currently holding shares of the company. FMR LLC is the top institutional holder at SANA for having 27.17 million shares of worth $148.35 million. And as of 2024-06-30, it was holding 12.5041 of the company’s outstanding shares.

The second largest institutional holder is FLAGSHIP PIONEERING INC., which was holding about 25.0 million shares on 2024-06-30. The number of shares represents firm’s hold over 11.5062 of outstanding shares, having a total worth of $136.51 million.